Universiteit Leiden

nl en

Cluster BioTherapeutics

Our research is aimed at a smoother and speedier transition from preclinical research to pharmacological interventions, and the delivery of drugs in the human body by use of small molecules and biologics.

Welcome to the Cluster of BioTherapeutics which combines the expertise of the divisions Biopharmaceutics (Prof. Kuiper and Prof. Van Eck) and Drug Delivery Technology (Prof. Bouwstra and Prof. Jiskoot).

Our work aimes at the innovative biopharmaceutical concepts to intervene in auto-immune-like disorders, using biologics such as vaccines and therapeutic proteins. We strive for an integration of our experimental in-vitro and in-vivo data, in order to develop quantitative systems biology models of health and disease states, thus enabling us to better predict efficacy and drug safety. A special aim lies in finding new targets in immune based diseases such as atheroscelrosis.


Research themes and principal investigators:

Immunotherapy to limit atherosclerosis

Contact: Johan Kuiper

In this research theme we aim to identify novel immunologic targets and apply immunotherapy to inhibit or even prevent the development of atherosclerosis.

Read more >


  • Project: Vaccination against atherosclerosis; induction of protective CD8 T-cells through immunization

    Contact: Bram Slütter

    My research covers two questions; what is the role of CD8 T-cells in atherosclerotic plaques and can protective CD8 T-cells be induced through vaccination?

Read more >


Therapeutic intervention to enhance atherosclerotic plaque stability

Contact: Ilze Bot

In this research theme we aim to identify target proteins or cells that actively contribute to plaque destabilization.

Read more>


Macrophages and atherosclerotic lesions

Contact: Miranda van Eck

The infiltration of monocytes in the arterial wall, their differentiation into macrophages, and the subsequent accumulation of cholesterol in these macrophages initiate the process of atherosclerosis. We study the importance of specific genes in macrophages for atherosclerotic lesion formation by means of bone marrow transplantation.

Read more>


Impaired barrier of inflammatory skin diseases

Contact: Joke Bouwstra

A strong focus in our research is to characterize in detail the impaired skin barrier properties in inflammatory skin diseases. Ultimately, we aim to normalize this barrier.

Read more >


Vaccine Delivery

Contacts: Gideon Kersten, Joke Bouwstra Wim Jiskoot 

The administration route of vaccines and the subsequent targeting towards the immune system can strongly influence the quality and acceptability of vaccines.

Read more >


Formulation of biopharmaceuticals

Contact: Wim Jiskoot

A major challenge in the formulation of biopharmaceuticals is to overcome their inherent instability. We are studying underlying mechanisms of degradation of biopharmaceuticals (especially therapeutic proteins and vaccines) in both liquid and dried formulations.

Read more >